UNSPSC 85251536: Diagnosis of malignant neoplasm on the posterior wall of hypopharynx

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Posterior wall of hypopharynx. Malignant neoplasm on the Posterior wall of hypopharynx is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C13. 2

UNSPSC 85251536 Diagnosis of malignant neoplasm on the posterior wall of hypopharynx is a Commodity code that shows minimal alignment with actual state and local procurement activity. The code nominally refers to a specific medical diagnosis, yet the recent opportunities tagged under it span diagnostic imaging systems implementation, school district special education services, and health system temporary staffing — none of which involve diagnosis or treatment of hypopharyngeal malignancy. The mismatch suggests either miscoding in the state and local procurement systems or a data classification error that has routed unrelated health care and education contracts to this taxonomy node.

The three most recent opportunities posted between July and October 2026 reflect this disconnection. San Mateo Medical Center (a county health system in California) solicited proposals for a diagnostic imaging PACS system integration with EPIC EHR, due October 21, 2026, as an RFP with local preference available under county ordinance. Birdville Independent School District (Texas) sought competitive sealed proposals for special education contracted services including audiologists, speech therapists, and behavioral specialists across 30 campuses, due October 21, 2026. Santa Clara County Health System (California) established a multiple-award qualified vendor pool for temporary staffing across 13 clinical service categories excluding nursing and physicians, due October 7, 2026 as a non-exclusive qualification vehicle. No recent opportunities under this code actually involve oncology diagnosis, treatment planning, or malignant neoplasm pathways. Vendors evaluating this code should verify classification accuracy with the issuing body before committing pursuit resources.